Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
105M
-
Shares change
-
-373K
-
Total reported value, excl. options
-
$594M
-
Value change
-
-$2.08M
-
Put/Call ratio
-
0.98
-
Number of buys
-
59
-
Number of sells
-
-54
-
Price
-
$5.67
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q1 2023
152 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q1 2023.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 105M shares
of 170M outstanding shares and own 61.47% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (23.1M shares), FMR LLC (18.9M shares), FEDERATED HERMES, INC. (15.3M shares), JANUS HENDERSON GROUP PLC (11.3M shares), BlackRock Inc. (6.25M shares), VANGUARD GROUP INC (5.85M shares), STATE STREET CORP (3.77M shares), Eversept Partners, LP (2.54M shares), GEODE CAPITAL MANAGEMENT, LLC (1.64M shares), and Avoro Capital Advisors LLC (1.3M shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.